In the present study, we simultaneously determined the mutations in the TERT and PLEKHS1 promoters and GPR126 intron 6 in UTUC tumors, compared the results with UBCs, and finally evaluated their potential clinical implications. The gene discussed is TERT; the disease is renal pelvis/ureter urothelial carcinoma.